Literature DB >> 20677900

Advances in novel drug delivery strategies for breast cancer therapy.

Ritu Dhankhar1, Suresh P Vyas, Arvind K Jain, Sahil Arora, Goutam Rath, Amit K Goyal.   

Abstract

Breast cancer remains one of the world's most devastating diseases. However, better understanding of tumor biology and improved diagnostic devices could lead to improved therapeutic outcomes. Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Various nanocarriers have been introduced to improve the therapeutic efficacy of anticancer drugs, including liposomes, polymeric micelles, quantum dots, nanoparticles, and dendrimers. Recently, targeted drug delivery systems for anti-tumor drugs have demonstrated great potential to lower cytotoxicity and increase therapeutic effects. Various ligands/approaches have been explored for targeting breast cancer. This paper provides an overview of breast cancer, conventional therapy, potential of nanotechnology in management of breast cancer, and rational approaches for targeting breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677900     DOI: 10.3109/10731199.2010.494578

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  17 in total

Review 1.  Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro; Luis Otávio Sarian; Manoela Marques Ortega; Sophie Françoise Derchain
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

Review 2.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment.

Authors:  Piumi Y Liyanage; Sajini D Hettiarachchi; Yiqun Zhou; Allal Ouhtit; Elif S Seven; Cagri Y Oztan; Emrah Celik; Roger M Leblanc
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

3.  Dextran-functionalized magnetic fluid mediating magnetohyperthermia for treatment of Ehrlich-solid-tumor-bearing mice: toxicological and histopathological evaluations.

Authors:  Ana Luisa Miranda-Vilela; Kelly Reis Yamamoto; Kely Lopes Caiado Miranda; Breno Noronha Matos; Marcos Célio de Almeida; João Paulo Figueiró Longo; José de Souza Filho; Juliana Menezes Soares Fernandes; Patrícia Pommé Confessori Sartoratto; Zulmira Guerrero Marques Lacava
Journal:  Tumour Biol       Date:  2013-12-01

4.  Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer.

Authors:  Marcella Lemos Brettas Carneiro; Raphael C A Peixoto; Graziela A Joanitti; Ricardo G S Oliveira; Luis A M Telles; Ana L Miranda-Vilela; Anamélia L Bocca; Leonora M S Vianna; Izabel C R da Silva; Aparecido R de Souza; Zulmira G M Lacava; Sônia N Báo
Journal:  J Nanobiotechnology       Date:  2013-02-16       Impact factor: 10.435

5.  Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.

Authors:  Sana Abbasi; Arghya Paul; Wei Shao; Satya Prakash
Journal:  J Drug Deliv       Date:  2011-12-08

Review 6.  Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.

Authors:  Mohamed I Nounou; Fatema ElAmrawy; Nada Ahmed; Kamilia Abdelraouf; Satyanarayana Goda; Hussaini Syed-Sha-Qhattal
Journal:  Breast Cancer (Auckl)       Date:  2015-09-27

7.  Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay.

Authors:  Raphael Cândido Apolinário Peixoto; Ana Luisa Miranda-Vilela; José de Souza Filho; Marcella Lemos' Brettas Carneiro; Ricardo G S Oliveira; Matheus Oliveira da Silva; Aparecido R de Souza; Sônia Nair Báo
Journal:  Tumour Biol       Date:  2014-12-21

8.  Analyses of the association between breast cancer and osteoporosis/fracture history: a cross-sectional study using KoGES HEXA data.

Authors:  Hyo Geun Choi; Yong Joon Suh; Jung Woo Lee; Chan Yang Min; Dae Myoung Yoo; Suk Woo Lee
Journal:  Arch Osteoporos       Date:  2021-06-19       Impact factor: 2.617

9.  Application of Clinical Decision Support System to Assist Breast Cancer Patients with Lifestyle Modifications during the COVID-19 Pandemic: A Randomised Controlled Trial.

Authors:  Panos Papandreou; Aristea Gioxari; Frantzeska Nimee; Maria Skouroliakou
Journal:  Nutrients       Date:  2021-06-20       Impact factor: 5.717

Review 10.  Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.

Authors:  Yurong Zhou; Jihong Sun; Xiaoming Yang
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.